ZA847405B - Pyridine-soluble extract-refined detoxified endotoxin composition and use - Google Patents

Pyridine-soluble extract-refined detoxified endotoxin composition and use

Info

Publication number
ZA847405B
ZA847405B ZA847405A ZA847405A ZA847405B ZA 847405 B ZA847405 B ZA 847405B ZA 847405 A ZA847405 A ZA 847405A ZA 847405 A ZA847405 A ZA 847405A ZA 847405 B ZA847405 B ZA 847405B
Authority
ZA
South Africa
Prior art keywords
pyridine
soluble extract
detoxified endotoxin
endotoxin composition
refined detoxified
Prior art date
Application number
ZA847405A
Other languages
English (en)
Inventor
John Leonard Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ZA847405B publication Critical patent/ZA847405B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA847405A 1983-09-23 1984-09-20 Pyridine-soluble extract-refined detoxified endotoxin composition and use ZA847405B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (1)

Publication Number Publication Date
ZA847405B true ZA847405B (en) 1985-05-29

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA847405A ZA847405B (en) 1983-09-23 1984-09-20 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Country Status (23)

Country Link
US (1) US4663306A (enExample)
JP (1) JPS60120817A (enExample)
KR (1) KR870000843B1 (enExample)
AT (1) AT385659B (enExample)
AU (1) AU566234B2 (enExample)
BE (1) BE900650A (enExample)
CA (1) CA1244765A (enExample)
CH (1) CH664897A5 (enExample)
DE (1) DE3434766C2 (enExample)
DK (1) DK446684A (enExample)
ES (1) ES8608872A1 (enExample)
FI (1) FI843716L (enExample)
FR (1) FR2552326B1 (enExample)
GB (1) GB2149301B (enExample)
HU (1) HU192585B (enExample)
IL (1) IL73034A (enExample)
IN (1) IN157240B (enExample)
IT (1) IT1179444B (enExample)
NL (1) NL8402902A (enExample)
NO (1) NO843776L (enExample)
NZ (1) NZ209635A (enExample)
SE (1) SE8404707L (enExample)
ZA (1) ZA847405B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
AU7488794A (en) * 1993-08-27 1995-03-21 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
PT1003525E (pt) 1997-08-05 2003-03-31 Bioniche Life Sciences Inc Composicao e metodo para a regulacao da proliferacao e da morte celular
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
JP4447779B2 (ja) * 1998-07-16 2010-04-07 市郎 東 細菌の菌体成分を有効成分とする癌免疫療法用製剤
DE60043759D1 (de) * 1999-12-13 2010-03-11 Bioniche Life Sciences Inc Therapeutisch nützliche synthetische Oligonukleotide
JP4215429B2 (ja) * 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
AR028800A1 (es) * 2000-07-11 2003-05-21 Bayer Ag Uso de cepas de parapoxvirus ovis contra fibrosis de organos
BR0215643A (pt) * 2002-03-05 2004-12-21 Cell Medicine Inc Adjuvante imunológico de tecido solidificado
JP4726485B2 (ja) * 2002-08-02 2011-07-20 大日本住友製薬株式会社 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
WO2005102369A1 (ja) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. 細菌細胞壁骨格成分を含有する製剤
HK1214510A1 (zh) 2013-04-18 2016-07-29 Immune Design Corp. 用於癌症治疗的gla单一疗法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP3158054B1 (en) 2014-06-17 2025-02-19 Crown Laboratories, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
US20210040055A1 (en) * 2017-08-17 2021-02-11 University Of Delaware Furan based compositions and methods of making thereof
EP4167937A4 (en) 2020-06-23 2024-11-13 Crown Laboratories, Inc. PROBIOTIC SKIN FORMULATIONS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (enExample) * 1972-06-20 1973-12-27
FR2269962B1 (enExample) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
HUT35521A (en) 1985-07-29
KR850002404A (ko) 1985-05-13
GB2149301B (en) 1988-06-22
IT1179444B (it) 1987-09-16
SE8404707D0 (sv) 1984-09-20
GB2149301A (en) 1985-06-12
JPS6254775B2 (enExample) 1987-11-17
BE900650A (fr) 1985-03-21
FI843716A7 (fi) 1985-03-24
ES8608872A1 (es) 1986-07-16
NO843776L (no) 1985-03-25
IL73034A (en) 1988-11-15
FR2552326A1 (fr) 1985-03-29
FI843716A0 (fi) 1984-09-21
AU3340084A (en) 1985-03-28
ES536167A0 (es) 1986-07-16
DE3434766C2 (de) 1987-05-14
AU566234B2 (en) 1987-10-15
FR2552326B1 (fr) 1988-05-13
NZ209635A (en) 1989-01-27
AT385659B (de) 1988-05-10
CH664897A5 (de) 1988-04-15
DE3434766A1 (de) 1986-04-30
CA1244765A (en) 1988-11-15
ATA302384A (de) 1987-10-15
IT8448894A0 (it) 1984-09-24
IN157240B (enExample) 1986-02-15
DK446684D0 (da) 1984-09-19
JPS60120817A (ja) 1985-06-28
HU192585B (en) 1987-06-29
SE8404707L (sv) 1985-03-24
KR870000843B1 (ko) 1987-04-25
US4663306A (en) 1987-05-05
GB8423993D0 (en) 1984-10-31
FI843716L (fi) 1985-03-24
NL8402902A (nl) 1985-04-16
DK446684A (da) 1985-03-24

Similar Documents

Publication Publication Date Title
ZA847405B (en) Pyridine-soluble extract-refined detoxified endotoxin composition and use
DE3464100D1 (en) Electric-cable structure and its application
GB2145422B (en) Novel poly-esters their preparation and pharmacolgical use thereof
EP0097960A3 (en) Bis-crown-ether derivatives and their use
ZA863957B (en) Alfuzosine compositions and use
DE3567660D1 (en) Optionally porous intumescent compositions and their use
SG4890G (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols preparation and uses
DE3374569D1 (en) Siloxane-polyester compositions and use thereof
IL71658A (en) 17-sulfonylmethylene-steroids and their preparation
GB2161381B (en) Detoxified endotoxin compositions
DE3467898D1 (en) Fluorine-containing copolymer and composition containing the same
ZA842431B (en) Novel anilines and their use
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
ZA842202B (en) Phenylaminobenzenealkanols and preparation
ZA893782B (en) Composition and use
DE3372983D1 (en) Radiation-sensible coating composition and its use
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
GB2147905B (en) Dye composition and use thereof
DE3471652D1 (en) Diurethane-diureas and use
IL73876A (en) 7-acylamino-mitosanes and their preparation
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
ZA846610B (en) Novel pyrazolylsulfonylureas and isoxazolylsulfonylureas
PH23727A (en) Imidazolylethoxyindanes and use as antithrombotic agents
DE3463048D1 (en) Furan-3-hydroxamates and their use
DE3466012D1 (en) Lubricant composition and its use